.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

MERIDIA Drug Profile

« Back to Dashboard
Meridia is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.

Summary for Tradename: MERIDIA

Patents:0
Applicants:1
NDAs:1
Drug Prices: :see details

Clinical Trials for: MERIDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-001Nov 22, 1997DISCNNo
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-002Nov 22, 1997DISCNNo
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-003Nov 22, 1997DISCNNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MERIDIA

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-001Nov 22, 19974,746,680*PED<disabled>
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-003Nov 22, 19974,929,629*PED<disabled>
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-003Nov 22, 19975,436,272*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: MERIDIA

Drugname Dosage Strength RLD Submissiondate
sibutramine hydrochlorideCapsules10 mg and 15 mgMeridia8/14/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc